Double-blind randomized trial of aflibercept versus placebo with docetaxel and prednisone for treatment of metastatic castration-resistant prostate cancer (mCRPC)
Yazar
Skoneczna, Iwona Anna
Tannock, Ian
Fizazi, Karim
Ivanov, Sergey
Thellenberg-Karlsson, Camilla
Flechon, Aude
Orlandi, Francisco Jorquera
Gravis, Gwenaelle
Matveev, Vsevolod
Bavbek, Sevil E.
Gil, Thierry
Viana, Luciano S.
Aren, Osvaldo
Karyakin, Oleg
Elliott, Tony
Birtle, Alison J.
Magherini, Emmanuelle
Petrylak, Daniel Peter
Tombal, Bertrand
Rosenthal, Mark
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]